125 related articles for article (PubMed ID: 6474526)
1. [Dosimetry in radiotherapy of the lower portion of the body in Hodgkin's disease. Dose distribution within the target volume dependent on radiotherapy].
Dorsch G; Müller RG; Sauer R
Strahlentherapie; 1984 Aug; 160(8):508-12. PubMed ID: 6474526
[TBL] [Abstract][Full Text] [Related]
2. [Dosimetry of lower segment irradiation in Hodgkin disease. II. Radiation burden of risk organs].
Dorsch G; Sauer R; Müller RG
Strahlentherapie; 1984 Sep; 160(9):527-34. PubMed ID: 6437019
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
[TBL] [Abstract][Full Text] [Related]
4. [Critical consideration of various irradiation methods in Hodgkin's disease].
Kärcher KH
Strahlentherapie; 1976 Feb; 151(2):176-82. PubMed ID: 1258088
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
6. Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?
Girinsky T; Pichenot C; Beaudre A; Ghalibafian M; Lefkopoulos D
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):218-26. PubMed ID: 16169675
[TBL] [Abstract][Full Text] [Related]
7. [A ventral mantle technic with dorsolateral mediastinal saturation in the radiotherapy of Hodgkin's disease].
Willich N; Bayer M; Krimmel K; Lengsfeld M; Rohloff R; Wendt T
Strahlenther Onkol; 1988 Jul; 164(7):393-401. PubMed ID: 3400047
[TBL] [Abstract][Full Text] [Related]
8. Dose distribution in the treatment of Hodgkin's disease.
Sorensen NE
Dan Med Bull; 1973 Mar; 20(2):47-51. PubMed ID: 4631779
[No Abstract] [Full Text] [Related]
9. Phantom measurements and computed estimates of breast dose with radiotherapy for Hodgkin's lymphoma: dose reduction with the use of the involved field.
Wirth A; Kron T; Wittwer H; Sullivan K; Sorell G; Cramb J
J Med Imaging Radiat Oncol; 2008 Aug; 52(4):394-402. PubMed ID: 18811765
[TBL] [Abstract][Full Text] [Related]
10. [Radiotherapy of para-aortal lymphomas with Co 60 gamma radiation (author's transl)].
Heckenthaler W; Ponhold W; Binder W; Kogelnik HD; Czech W
Strahlentherapie; 1981 Jan; 157(1):1-7. PubMed ID: 7210040
[TBL] [Abstract][Full Text] [Related]
11. [Radiotherapy in adults with localized supradiaphragmatic stages CS I/II of Hodgkin's disease. 2. The special aspects of radiotherapy: dosage, fractionation, focal volumes, risks, conclusions].
Glanzmann C; Lütolf UM
Strahlenther Onkol; 1993 Oct; 169(10):570-83. PubMed ID: 8235981
[TBL] [Abstract][Full Text] [Related]
12. Mantle field dosimetry comparing 4 MV with cobalt 60.
Gray L; Prosnitz LR
Radiology; 1975 Aug; 116(02):429-32. PubMed ID: 807948
[TBL] [Abstract][Full Text] [Related]
13. A method for the calculation of dose in the radiation treatment of Hodgkin's disease.
Cundiff JH; Cunningham JR; Golden R; Lanzi LH; Meurk ML; Ovadia J; Last VP; Pope RA; Sampiere VA; Saylor WL; Shalek RJ; Suntharalingham N
Am J Roentgenol Radium Ther Nucl Med; 1973 Jan; 117(1):30-44. PubMed ID: 4631094
[No Abstract] [Full Text] [Related]
14. [Pericarditis after wide field irradiation for Hodgkin's disease study of dosimetry in relation to therapeutic consequences (author's transl)].
Dana M; Colombel P; Bayle-Weisgerber C; Teillet F; Desprez-Curely JP; Bernard J; Chotin G
J Radiol Electrol Med Nucl; 1978 May; 59(5):335-41. PubMed ID: 690957
[No Abstract] [Full Text] [Related]
15. Comparison of three different mediastinal radiotherapy techniques in female patients: Impact on heart sparing and dose to the breasts.
Nieder C; Schill S; Kneschaurek P; Molls M
Radiother Oncol; 2007 Mar; 82(3):301-7. PubMed ID: 17156873
[TBL] [Abstract][Full Text] [Related]
16. [Radiation treatment of Hodgkin's disease (author's transl)].
Gyenes G; Petrànyi J; Varjas G
Arch Geschwulstforsch; 1978; 48(5):419-21. PubMed ID: 747515
[TBL] [Abstract][Full Text] [Related]
17. [Radiotherapy in Hodgkin's disease. Practical aspects].
Schlienger M; Le Bourgeois JP; Eschwège F
Rev Prat; 1974 Oct; 24(45):3945-6, 3949-53. PubMed ID: 4216952
[No Abstract] [Full Text] [Related]
18. Intensity-modulated radiotherapy for lymphoma involving the mediastinum.
Goodman KA; Toner S; Hunt M; Wu EJ; Yahalom J
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):198-206. PubMed ID: 15850922
[TBL] [Abstract][Full Text] [Related]
19. Electronic compensation using multileaf collimation for involved field radiation to the neck and mediastinum in non-Hodgkin's lymphoma and Hodgkin's lymphoma.
MacDonald S; Bernard S; Balogh A; Spencer D; Sawchuk S
Med Dosim; 2005; 30(2):59-64. PubMed ID: 15922170
[TBL] [Abstract][Full Text] [Related]
20. Doses to organs at risk from mantle field radiation therapy using 10 MV x-rays.
Wong PS; Rosemark PJ; Wexler MC; Greenberg SH; Thompson RW
Mt Sinai J Med; 1985 Mar; 52(3):216-20. PubMed ID: 3873004
[No Abstract] [Full Text] [Related]
[Next] [New Search]
